SSGJ-707
- Generic Name
- SSGJ-707
SSGJ-707 in Advanced Non-Small Cell Lung Cancer
Phase 3
Not yet recruiting
- Conditions
- Advanced Non-Small Cell Lung Cancer
- Interventions
- First Posted Date
- 2025-05-20
- Last Posted Date
- 2025-05-20
- Lead Sponsor
- Shenyang Sunshine Pharmaceutical Co., LTD.
- Target Recruit Count
- 420
- Registration Number
- NCT06980272
- Locations
- 🇨🇳
The Shanghai East Hospital, Shanghai, China
A Study to Evaluate SSGJ-707 in Advanced Gynecologic Cancer Patients
Phase 2
Recruiting
- Conditions
- Advanced/recurrent Endometrial Cancer and Platinum-resistant Ovarian Cancer
- Interventions
- First Posted Date
- 2024-07-26
- Last Posted Date
- 2024-10-21
- Target Recruit Count
- 80
- Registration Number
- NCT06522828
- Locations
- 🇨🇳
Chongqing Cancer Hospital, Chongqing, China
A Phase 2 Study of SSGJ-707 in Metastatic Colorectal Cancer Patients
Phase 2
Not yet recruiting
- Conditions
- Metastatic Colorectal Cancer
- Interventions
- First Posted Date
- 2024-07-10
- Last Posted Date
- 2024-08-09
- Target Recruit Count
- 130
- Registration Number
- NCT06493760
- Locations
- 🇨🇳
Liu Tianshu, Shanghai, Shanghai, China
A Phase II Study of SSGJ-707 Combination Therapy in Advanced NSCLC Patients
Phase 2
Recruiting
- Conditions
- First-line Advanced NSCLC Patients
- Interventions
- Drug: Paclitaxel-albuminDrug: PD-1/L1
- First Posted Date
- 2024-05-14
- Last Posted Date
- 2024-07-30
- Target Recruit Count
- 235
- Registration Number
- NCT06412471
- Locations
- 🇨🇳
Institute of The Hunan Cancer Hospital, Changsha, China
A Phase II Study of SSGJ-707 Monotherapy in First-line PD-L1 Positive Advanced NSCLC Patients
- First Posted Date
- 2024-04-12
- Last Posted Date
- 2024-05-16
- Target Recruit Count
- 120
- Registration Number
- NCT06361927
- Locations
- 🇨🇳
The Hunan Cancer Hospital, Changsha, Hunan, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath